Chemotherapy and Parenteral Nutrition
Mobile Healthcare
coming soon
LadyExam
coming soon
EyeScreen
coming soon
Cancer development is an asymptomatic process in which normal cells gradually become malignant through a progressive series of alterations.
Active detection of asymptomatic cancer saves lives. Many cancers can be treated when diagnosed in time through mandatory screening programs for women.
The sensitivity of the method is from 47 to 80%; Sensitivity depends on the qualification and area of the doctor.
The specificity of the method is up to 99%.
The efficiency of the method decreases while detecting early stages of cancer and in women of young age
Only 8% of women perform self-surveys (BSE) regularly, and 36% periodically.
The sensitivity of the method is only 26%.
Mammography is obligatory once every two years for women aged 50-70 years. In some countries, the age is lowered to 40 years.
The sensitivity of the method is 85-87%.
In mammary glands with a high content of fatty tissue, sensitivity is close to 100% (menopausal women).
The specificity of the method is 91-92%.
The increased density of mammary glands and heterogeneity of structure decreased the sensitivity of the method to 41%.
One of the common methods of early detection of oncopathology in women. The sensitivity of the method is 80%, while its specificity amounts to 88,4%.
This is a routine and highly effective method of preventive screening for various cervical diseases
Detection in the late stages
Is an immediate cause of the high mortality rate
Is the main reason for the low detection rate of cancer
The OneScreen LadyExam ecosystem is specifically designed for early detection of precancerous lesions and cancer
eHealth solutions
Lab values
Radiation therapy
Chemo-, targeted and Immunotherapy
Surgery, Ablation
Pet/CT
SPECT/CT
eHealth solutions
Risk factors
Imaging
MRI
Pet/CT
Mammo
SPECT/CT
Ultra-sound
BreastExam
CervExam
Colco
PAP
MRI
Clinically proven reliability
Rapid non-invasive exam
Simple and convenient
Innovative portable digital devices
Instant results
Sensitivity
NPV
Specificity
Remote monitoring of treatment and condition of patients.
Wide population coverage
Integration with Medical Information Systems (MIS)
Telemedicine
No special knowledge is required to perform the test
The test can be performed by any health care professional
Painless for the patient
Fast
Doctor's office
Hospital
Home
The ecosystem includes a web-portal with artificial intelligence and a set of portable digital diagnostic devices
Identifying and documenting clinically significant changes in female health at the primary community care level
mHealth portable wireless devices.
It's convenient, easy and requires no special knowledge or skills
Comes with a web-portal for diagnostics and patient monitoring, artificial intelligence, telemedicine, real-time data transfer, clinical data analysis center.
Can be integrated with the hospital's MIS and eHealth system.